About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
ELCC 2019: European Lung Cancer Congress
AACR Annual Meeting 2019
NCCN Annual Conference 2019
2019 SGO Annual Meeting on Womens Cancer
2019 Multidisciplinary Thoracic Cancers Symposium
Biomarkers in Immunotherapy
IMPROVING NSCLC OUTCOMES
Methotrexate–Induced Kidney Injury
No results found for "Hagop M. Kantarjian, MD"
Ensure words are spelled correctly.
Try rephrasing keywords or using synonyms.
Try less specific keywords.
Today In Oncology
FDA Pipeline: Designations for Myelodysplastic Syndromes, Triple-Negative Breast Cancer, AML, and EBV-Associated Cancers
Gene Fusions Detected at Low Incidence Across Multiple Tumor Types
Primary Surgery Outcomes in MRI-Based ‘Good-Prognosis’ Rectal Cancer
Patient-Reported Outcomes With Salvage Autologous Stem Cell Transplantation vs Nontransplantation in Relapsed Multiple Myeloma
Study Finds Medicaid Reimbursement for Radiation Therapy Varies Widely State-to-State
Most Read Stories
Treatment of Patients With Imminently Fatal de Novo Metastatic Cancer
How I Work up the Patient with Thrombocytosis
Factors Contributing to Improved Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
Full Disclosure: What Oncologists Must Tell Patients About Their Experience and Training
FDA Expands Pembrolizumab Indication for NSCLC in First-Line Setting
© 2019 HSP News Service, L.L.C.